XML 89 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Schedule of Deferred Income Tax Assets and Liabilities

Significant components of the Company deferred tax assets and liabilities are as follows:

 

   December 31, 
   2024   2023 
         
Net operating loss carryforward  $2,066,962   $1,845,821 
Research and development expenses   205,513    218,728 
Provision for warranty   3,450    9,584 
Provision for vacation and convalescence   82,579    69,048 
Provision for severance, net   60,911    70,656 
Provision for credit losses   186,377    74,741 
Issuance cost   203,045    184,781 
Operating lease liabilities   109,368    103,698 
           
Deferred tax assets before valuation allowance   2,918,205    2,577,057 
           
Valuation allowance   (2,808,837)   (2,473,359)
           
Net deferred tax assets   109,368    103,698 
           
Operating lease right of use assets   (109,368)   (103,698)
           
Total deferred tax liability   (109,368)   (103,698)
           
Net deferred tax assets  $
-
   $
-
 
Schedule of Net Changes in the Total Valuation Allowance

The net changes in the total valuation allowance as of December 31, 2024 and 2023, are comprised as follows:

 

   December 31, 
   2024   2023 
         
Balance at beginning of year  $2,473,359   $1,907,486 
Additions during the year   444,846    565,873 
           
Balance at the end of year  $2,918,205   $2,473,359